Brian A. Staton

974 total citations
7 papers, 501 citations indexed

About

Brian A. Staton is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, Brian A. Staton has authored 7 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Brian A. Staton's work include Cancer therapeutics and mechanisms (2 papers), Advanced Breast Cancer Therapies (2 papers) and Lung Cancer Research Studies (2 papers). Brian A. Staton is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Advanced Breast Cancer Therapies (2 papers) and Lung Cancer Research Studies (2 papers). Brian A. Staton collaborates with scholars based in United States, Spain and Sweden. Brian A. Staton's co-authors include Thomas J. Raub, Rose T. Ajamie, Harlan E. Shannon, Concepción Sánchez‐Martínez, Geri A. Sawada, Alfonso de Dios, Lawrence M. Gelbert, Graham N. Wishart, Palaniappan Kulanthaivel and Larry J. Schaaf and has published in prestigious journals such as Journal of Clinical Oncology, Neuropharmacology and Molecular Cancer Therapeutics.

In The Last Decade

Brian A. Staton

7 papers receiving 481 citations

Peers

Brian A. Staton

ONCOL

PRM

MB

GENET

CR

M. Eileen Dolan United States

K. Bélanger Canada

Flora Luo United States

Chu Myong Seong South Korea

Shuji Terao Japan

A. Jeanson France

Allan Torneros Japan

Stephen Schmidt United States

Robert J. Cardnell United States

Chaitanya Iragavarapu United States

M. Eileen Dolan United States

Brian A. Staton

237 ×0.7

ONCOL

67 ×0.3

PRM

332 ×1.7

MB

113 ×1.3

GENET

88 ×2.3

CR

Citations per year, relative to Brian A. Staton Brian A. Staton (= 1×) peers M. Eileen Dolan

Countries citing papers authored by Brian A. Staton

Since Specialization

Citations

This map shows the geographic impact of Brian A. Staton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Staton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Staton more than expected).

Fields of papers citing papers by Brian A. Staton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Staton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Staton. The network helps show where Brian A. Staton may publish in the future.

Co-authorship network of co-authors of Brian A. Staton

This figure shows the co-authorship network connecting the top 25 collaborators of Brian A. Staton. A scholar is included among the top collaborators of Brian A. Staton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian A. Staton. Brian A. Staton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Raub, Thomas J., Graham N. Wishart, Palaniappan Kulanthaivel, et al.. (2015). Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft. Drug Metabolism and Disposition. 43(9). 1360–1371. 207 indexed citations

2.

Sánchez‐Martínez, Concepción, Lawrence M. Gelbert, Harlan E. Shannon, et al.. (2011). Abstract B234: LY2835219, a potent oral inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6) that crosses the blood-brain barrier and demonstrates in vivo activity against intracranial human brain tumor xenografts.. Molecular Cancer Therapeutics. 10(11_Supplement). B234–B234. 27 indexed citations

3.

Rodríguez, C.A., Nkechi Azie, Kirsteen Donaldson, et al.. (2004). Single Oral Dose Safety, Tolerability, and Pharmacokinetics of PNU‐96391 in Healthy Volunteers. The Journal of Clinical Pharmacology. 44(3). 276–283. 15 indexed citations

4.

Cimini, Maria, et al.. (2002). PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson’s Disease. Neuropharmacology. 43(5). 817–824. 12 indexed citations

5.

Drengler, Ronald, John G. Kuhn, Larry J. Schaaf, et al.. (1999). Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors. Journal of Clinical Oncology. 17(2). 685–685. 85 indexed citations

6.

Saltz, Leonard B., Nancy E. Kemeny, Larry J. Schaaf, et al.. (1996). Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.. Journal of Clinical Oncology. 14(11). 2959–2967. 131 indexed citations

7.

Staton, Brian A., et al.. (1995). Simple, rapid and sensitive high-performance liquid chromatographic determination of delavirdine and its N-desisopropyl metabolite in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 668(1). 99–106. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact